Drugs / Autologous Mesenchymal Stromal Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06798623 | Mar 2026 → Mar 2028 expected | — | The Methodist Hospital Research Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Mesenchymal Stromal Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06798623 ↗ |
| Modality | Cell therapy | “autologous mesenchymal stromal cells” NCT06798623 ↗ |
| Route | Other | “one intra-articular injection” NCT06798623 ↗ |